-
PurposeCloning vector for CRISPR-sgRNA (into the BamHI-EcoRI site), expresses RFP and hygromycin resistance gene.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 60601 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepHL-MCS1
-
Backbone manufacturerHotta Lab, CiRA
- Backbone size w/o insert (bp) 2043
- Total vector size (bp) 6946
-
Vector typeMammalian Expression, CRISPR
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DB3.1
-
Growth instructionsccdB resistant strain of E.coli is required.
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameRed Fluorescent Protein
-
Alt namemRFP1
-
SpeciesDiscosoma sp
-
Insert Size (bp)678
Cloning Information for Gene/Insert 1
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRV (not destroyed)
- 3′ cloning site BlnI (not destroyed)
- 5′ sequencing primer N.A.
- 3′ sequencing primer N.A. (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameHygromycin resistance gene
-
Alt nameHygroR
-
SpeciesE.coli
-
Insert Size (bp)1026
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer N.A.
- 3′ sequencing primer N.A. (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pHL-H1-ccdB-mEF1a-RiH was a gift from Akitsu Hotta (Addgene plasmid # 60601 ; http://n2t.net/addgene:60601 ; RRID:Addgene_60601) -
For your References section:
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9. Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A. Stem Cell Reports. 2014 Nov 25. pii: S2213-6711(14)00335-X. doi: 10.1016/j.stemcr.2014.10.013. 10.1016/j.stemcr.2014.10.013 PubMed 25434822